Director Of Clinical Research Eight SleepDirector Of Clinical ResearchBoston, MAYou will also own program management across the full breadth of the clinical team's verticals - hardware studies, AI/ML development studies, and women's sleep studies - while also acting as Eight Sleep's public-facing voice on the science of sleep, from peer-reviewed publications to press and podcast appearances. Provide scientific input on marketing claims, press releases, and journalist articles by reviewing web, social, and app content for accuracy and ensuring every public-facing claim and document is backed by data.
Director/Sr Director Pharmacometrics Eli Lilly and CompanyDirector/Sr Director PharmacometricsBoston, MA$177,000–$308,000 / yearOur current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women's Initiative for Leading at Lilly (WILL). Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve.
Director of Clinical Research Eight SleepDirector of Clinical ResearchBoston, MassachusettsYou will also own program management across the full breadth of the clinical team's verticals — hardware studies, AI/ML development studies, and women’s sleep studies — while also acting as Eight Sleep's public-facing voice on the science of sleep, from peer-reviewed publications to press and podcast appearances. Provide scientific input on marketing claims, press releases, and journalist articles by reviewing web, social, and app content for accuracy and ensuring every public-facing claim and document is backed by data.
Director Of Quality Systems ElucidDirector Of Quality SystemsBoston, MARemote$175,000–$225,000 / yearDeep hands-on experience guiding software development lifecycle activities in an agile environment with monthly releases (testing strategy, design transfer, release processes, etc.), working with Product and Engineering teams to maintain compliance and champion a culture of quality. We are a rapidly growing, Boston-based medical technology company using AI to enable clinicians to make informed decisions on cardiovascular care - leading to better patient outcomes, improved quality of care, and reduced healthcare costs.
Associate Director, ExploR&D Consultation Agreements Eli Lilly and CoAssociate Director, ExploR&D Consultation AgreementsBoston, MA$132,000–$193,600 / yearOur current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women's Initiative for Leading at Lilly (WILL). Through its interconnected pillars - Lilly Ventures, Lilly Gateway Labs, Lilly ExploR&D, and Lilly TuneLab - Catalyze360 strategically removes barriers that traditionally block bold science from becoming life-changing medicines, providing biotechs with flexible combinations of capital, physical lab space, R&D capabilities, AI/ML tools, and decades of enterprise learning.
Associate Director, Thought Leader Liaison, Ophthalmology, Northeast Mallinckrodt LLCAssociate Director, Thought Leader Liaison, Ophthalmology, NortheastBoston, MARemote$160,000–$228,000 / yearThe Thought Leader Liaison (TLL) is responsible for developing, managing, and engaging with Key Opinion Leaders throughout their assigned geography reporting to the Thought Leader Liaison Lead, reporting through Specialty Brands Marketing. Strong relationship building skills, with proven ability to build and maintain lasting relationships with KOLs and navigate strategic accounts (Integrated Delivery Networks, Academic Medical Centers, Centers of Excellence, etc.).
Director, Intellectual Property Deciphera Pharmaceuticals IncDirector, Intellectual PropertyWaltham, MA$218,000–$300,000 / yearROMVIMZA (vimseltinib) is a kinase inhibitor approved in the United States for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity, and in the European Union for adult patients with TGCT associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability. In addition to advancing multiple product candidates from Deciphera's platform in clinical studies, QINLOCK (ripretinib) is Deciphera's switch-control kinase inhibitor approved in many countries including the European Union and the United States for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.
Associate Director, Marketing - Romvimza Deciphera Pharmaceuticals IncAssociate Director, Marketing - RomvimzaWaltham, MA$174,000–$239,000 / yearROMVIMZA (vimseltinib) is a kinase inhibitor approved in the United States for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity, and in the European Union for adult patients with TGCT associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability. In addition to advancing multiple product candidates from Deciphera's platform in clinical studies, QINLOCK (ripretinib) is Deciphera's switch-control kinase inhibitor approved in many countries including the European Union and the United States for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.
Senior Director, Focused Ultrasound Drug Delivery Eli Lilly and CoSenior Director, Focused Ultrasound Drug DeliveryBoston, MA$166,500–$264,000 / yearThis role anchors a growing technical capability in ultrasound-mediated delivery - spanning focused ultrasound (FUS) for deep-tissue and organ-specific targets as well as non-focused ultrasound approaches where spatial precision is not required for the target bioeffect - including microbubble/nanobubble-mediated bioeffects such as sonoporation and reversible barrier permeabilization, intended to enhance delivery of biologics and gene therapies across a range of deep and superficial tissue targets and emerging routes of administration. Job Position Overview: The Drug Delivery group at Lilly studies physiological barriers across routes of administration to create novel, patient-centric delivery solutions, serving as a center of excellence in injection physiology, device ideation, novel drug delivery technologies across modalities and routes of administration, nanomedicine and targeted delivery, and connected devices/digital biomarkers.
Senior Director, Health Economics & Outcomes Research (HEOR) Tetraphase Pharmaceuticals IncSenior Director, Health Economics & Outcomes Research (HEOR)Waltham, MAXACDURO (sulbactam for injection; durlobactam for injection) is a new treatment designed specifically to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex in adults. ZEVTERA (ceftobiprole) is an approved advanced-generation cephalosporin antibiotic and the only FDA-approved cephalosporin specifically designed to treat adult patients with Staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis.
Director, Systems Architecture, Planning & Security Tetraphase Pharmaceuticals IncDirector, Systems Architecture, Planning & SecurityWaltham, MAXACDURO (sulbactam for injection; durlobactam for injection) is a new treatment designed specifically to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex in adults. ZEVTERA (ceftobiprole) is a newly approved advanced-generation cephalosporin antibiotic and the only FDA-approved cephalosporin specifically designed to treat adult patients with Staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis.
Senior Director, Product Quality Lead (Post-Marketing and Pharmacovigilance Madrigal PharmaceuticalsSenior Director, Product Quality Lead (Post-Marketing and PharmacovigilanceWaltham, Massachusetts$244,000–$299,000 / yearAs a key member of the Quality leadership team, you will partner closely with Pharmacovigilance, Regulatory Affairs, Manufacturing, and Commercial teams to embed quality across the full product lifecycle, with particular focus on post-marketing safety surveillance, literature monitoring, and Product Quality Complaints (PQC). Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality.
Director Of Product ElucidDirector Of ProductBoston, MARemote$195,000–$230,000 / yearWe are a rapidly growing, Boston-based medical technology company using AI to enable clinicians to make informed decisions on cardiovascular care - leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The ideal candidate will have: 7+ years of product management experience within Software as a Medical Device (SaMD), preferably in medical imaging, including experience leading teams of product managers.
Associate Director, Data Engineering Formation Bio IncAssociate Director, Data EngineeringBoston, MA$213,500–$267,000 / yearPartner with key stakeholders such as: Data Science, Analytics, Clinical Operations, Data Managers, and Business Development on the design and delivery of pipelines and data models that support operational reporting, asset evaluation, and advanced analytics and ML use cases, ensuring your team designs solutions that close gaps and sees them through from concept to implementation. As the Associate Director of Data Engineering, you''ll lead the team responsible for that data platform, and this role is about multiplying their impact: you''re accountable for the pipelines, warehouse, and data products they build, for how fast and how well they build them, and for creating the conditions in which the engineers who build and operate them can grow, perform at a high level, and sustain that performance over time.
Director, SC Systems Johnson & JohnsonDirector, SC SystemsRaynham, MARequired Skills: Preferred Skills: Budget Management, Business Savvy, Corporate Finance, Data Quality, Developing Others, Execution Focus, Expense Controls, Financial Analysis, Financial Forecasting, Financial Reports, Financial Risk Management (FRM), Inclusive Leadership, Internal Controls, Leadership, Risk Management, Sarbanes-Oxley Compliance, Succession Planning, Tactical Planning, Vendor Management. The process of the planned separation is anticipated to be completed within 18 to 24 months, subject to legal requirements, including consultation with works councils and other employee representative bodies, as may be required, regulatory approvals and other customary conditions and approvals.
Director/Senior Director of Asset Quality Assurance Formation Bio IncDirector/Senior Director of Asset Quality AssuranceBoston, MA$185,500–$232,000 / yearYou hold a bachelor's or advanced degree in a scientific, engineering, or related discipline, with extensive multidisciplinary GxP experience in biopharma quality assurance leadership, ideally within a fast-paced biotech that has successfully transitioned from early-stage to commercial. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials.
Associate Director, Real World Data Formation Bio IncAssociate Director, Real World DataBoston, MA$204,500–$267,000 / yearRecognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Partner with Data Science, Clinical Development, Business Development, and Engineering teams to define RWD use cases (trial feasibility, synthetic control arms, epidemiology, label expansion) and productize ad hoc pipelines into scalable, production-grade systems.
Director, Product Quality Lead Tetraphase Pharmaceuticals IncDirector, Product Quality LeadWaltham, MAXACDURO (sulbactam for injection; durlobactam for injection) is a new treatment designed specifically to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex in adults. ZEVTERA (ceftobiprole) is a newly approved advanced-generation cephalosporin antibiotic and the only FDA-approved cephalosporin specifically designed to treat adult patients with Staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis.
Associate Director, Consumer Marketing, GA Apellis Pharmaceuticals IncAssociate Director, Consumer Marketing, GAWaltham, MA$179,000–$269,000 / yearCompany Background: Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases.
Sr. Director Product Management Fortive CorporationSr. Director Product ManagementBoston, MA$133,600–$248,500 / yearProvation’s comprehensive portfolio spans the entire patient encounter, from pre-procedure through post-procedure, with solutions for physician and nursing documentation (Provation® MD, Provation® Apex, MD-Reports, Provation® endoPRO®, and Provation® MultiCaregiver), anesthesia documentation (#1 Best in KLAS Provation® iPro), patient engagement, surgical care coordination, quality reporting, and billing capture (Provation® SurgicalValet™), order set and care plan management (Provation® Order Set Advisor™ and Provation® Care Plans), and EHR embedded clinical documentation (Provation® Clinic Note). We're a force for progress, working alongside our customers and partners to solve challenges on a global scale, from workplace safety in the most demanding conditions to advanced technologies that help providers focus on exceptional patient care.